PTK/ZK in Disseminated Malignant Melanoma

NCT00615160 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Substance was withdrawn from further development.

Conditions

Melanoma

Interventions

DRUG: PTK787/ZK 222584
DRUG: Dacarbazine

Sponsor

Michael Weichenthal